Generating sales is critical for any business, so it’s good to get someone on who has a playbook that works. Mads Jensen of SuperSeed focuses on B2B SaaS, helping his investee companies get those early sales and, when appropriate, scale up.
We talk about the challenges for start-ups: how to find those early customers, the difference between soliciting enough customer feedback and losing focus, when you know you have customer market fit and when to start scaling your sales up. We also talk about pricing and the role investors can play.
Please email [email protected] if you have any questions or comments on The EIS Navigator.
Never miss an episode – click here to subscribe to The EIS Navigator on most popular services.
Mads Jensen is the Managing Partner of SuperSeed. A successful entrepreneur and passionate technologist (having authored multiple US patents), he has worked for two decades building and growing tech businesses. At SuperSeed he helps ambitious technical founders build great companies from the early stages. Prior to SuperSeed, Mads was an entrepreneur, taking Sefaira (a SaaS company) from inception in 2009 to exit in 2016. Before that he was a business executive at IBM.
SuperSeed www.superseed.com
Good Strategy/Bad Strategy: The difference and why it matters by Richard Rumelt
Disclaimer
Please note this podcast/interview does not constitute a financial promotion and is provided for informational purposes and should not be construed as an invitation or offer to buy or sell any investments. Please be aware that investments into unquoted companies are high risk, long term and illiquid investments. Your capital is at risk. Past performance is not a reliable indicator of future performance. Target returns are not guaranteed and forward looking statements are illustrative only and must not be relied upon. Investors should only invest on the basis of reading the full offer documentation. Listeners must make their own independent decisions and obtain their own independent advice regarding any information, projects, securities, tax treatment or financial instruments mentioned herein.
